Profile data is unavailable for this security.
About the company
Formycon AG is a Germany based Company. The Company is engaged in providing biosimilar drugs and formulations. The Company focuses on treatments in ophthalmology, immunology and other chronic diseases, covering all steps of biosimilar development process, from early-stage analysis of the originator drug to the preclinical and clinical testing phases, as well as the preparation of dossiers for marketing approval.
- Revenue in EUR (TTM)69.67m
- Net income in EUR-125.67m
- Incorporated2012
- Employees250.00
- LocationFormycon AGFraunhoferstrasse 15, PlaneggMARTINSRIED 82152GermanyDEU
- Phone+49 89 864667100
- Fax+49 89 864667110
- Websitehttps://www.formycon.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Faron Pharmaceuticals Oy | 0.00 | -25.92m | 269.50m | 25.00 | -- | -- | -- | -- | -0.2682 | -0.2682 | 0.00 | -0.0808 | 0.00 | -- | -- | 0.00 | -227.96 | -227.46 | -- | -1,738.54 | -- | -- | -- | -- | -- | -2.58 | 5.15 | -- | -- | -- | 16.24 | -- | 17.71 | -- |
| Intellego Technologies AB | 34.76m | 11.38m | 321.26m | 64.00 | 26.77 | 9.14 | 23.95 | 9.24 | 4.36 | 4.36 | 13.73 | 12.78 | 0.9208 | 7.19 | 1.81 | 6,266,242.00 | 30.14 | 17.13 | 37.97 | 23.87 | 66.50 | 58.82 | 32.74 | 21.32 | 3.27 | 9.84 | 0.0997 | -- | 42.25 | 222.71 | 14.78 | -- | -- | -- |
| Puretech Health PLC | 4.13m | 45.78m | 363.90m | 56.00 | 7.42 | 1.02 | 13.57 | 88.10 | 0.1764 | 0.1764 | 0.014 | 1.28 | 0.0075 | -- | 2.48 | 63,867.54 | 4.29 | -3.27 | 4.57 | -3.83 | -- | -- | 575.43 | -253.25 | -- | -- | 0.052 | -- | 44.98 | -13.21 | 181.45 | -33.81 | -75.53 | -- |
| Inventiva SA | 9.20m | -184.21m | 385.45m | 109.00 | -- | -- | -- | 41.91 | -2.94 | -2.94 | 0.1539 | -1.11 | 0.0976 | -- | 4.24 | 84,385.32 | -195.09 | -80.43 | -2,085.15 | -122.98 | -- | -- | -1,999.35 | -989.96 | 0.9236 | -1.10 | -- | -- | -47.37 | 5.62 | -66.82 | -- | 19.61 | -- |
| Valneva SE | 186.06m | -80.39m | 428.19m | 695.00 | -- | 2.33 | -- | 2.30 | -0.5015 | -0.5015 | 1.23 | 1.08 | 0.3778 | 1.80 | 6.12 | 267,709.30 | -16.32 | -14.46 | -21.08 | -23.62 | 46.56 | 34.12 | -43.21 | -34.54 | 2.12 | -3.49 | 0.5465 | -- | 10.32 | 6.09 | 87.93 | -- | 8.60 | -- |
| Oxford BioMedica plc | 148.74m | -49.88m | 431.47m | 861.00 | -- | 6.54 | -- | 2.90 | -0.414 | -0.414 | 1.24 | 0.5384 | 0.5322 | 5.73 | 4.71 | 149,590.00 | -20.09 | -20.23 | -25.99 | -25.48 | 41.17 | 49.36 | -37.74 | -45.03 | 2.05 | -5.42 | 0.6426 | -- | 43.84 | 14.99 | 72.58 | -- | -21.89 | -- |
| Abivax SA | 0.00 | -176.24m | 451.29m | 67.00 | -- | 11.10 | -- | -- | -2.80 | -2.80 | 0.00 | 0.6407 | 0.00 | -- | -- | 0.00 | -66.22 | -66.33 | -101.41 | -100.02 | -- | -- | -- | -- | -- | -114.33 | 0.7033 | -- | -- | -- | -19.29 | -- | -7.33 | -- |
| Allergy Therapeutics plc | 64.28m | -41.17m | 454.13m | 602.00 | -- | -- | -- | 7.07 | -0.0075 | -0.0075 | 0.0117 | -0.0015 | 0.7836 | 2.15 | 6.00 | 92,453.49 | -50.19 | -22.88 | -78.92 | -30.15 | 54.04 | 66.47 | -64.05 | -24.88 | 1.15 | -4.07 | 1.19 | -- | -7.36 | -5.62 | 6.63 | -- | 1.88 | -- |
| Formycon AG | 69.67m | -125.67m | 529.05m | 250.00 | -- | 1.15 | -- | 7.59 | -7.11 | -7.11 | 3.98 | 26.15 | 0.0838 | 150.45 | 2.37 | 278,696.00 | -15.12 | -1.47 | -16.12 | -1.58 | 21.29 | 25.54 | -180.37 | -13.00 | 2.80 | -1.87 | 0.0224 | -- | -10.32 | 15.48 | -265.81 | -- | 96.87 | -- |
| Idorsia Ltd | 173.26m | -247.54m | 569.49m | 938.00 | -- | -- | -- | 3.29 | -1.37 | -1.37 | 0.7856 | -5.57 | 0.2609 | 0.5722 | 5,866.66 | -- | -37.27 | -48.63 | -93.44 | -61.12 | 78.41 | -- | -142.87 | -526.39 | 0.3785 | -41.16 | 42.60 | -- | -26.17 | 36.41 | 11.47 | -- | -1.08 | -- |
| Philogen SpA | 74.00m | 45.29m | 643.34m | 183.00 | 19.58 | 6.40 | 13.08 | 8.69 | 1.12 | 1.12 | 1.84 | 3.44 | 0.5144 | 5.69 | 22.25 | 404,349.70 | 31.48 | 0.7964 | 35.06 | 0.8907 | 78.83 | 58.86 | 61.21 | 3.70 | 7.76 | -- | 0.0769 | -- | 219.91 | 42.46 | 835.14 | 100.38 | 10.46 | -- |
| Basilea Pharmaceutica AG Allschwil | 223.96m | 83.33m | 689.18m | 164.00 | 8.62 | 7.19 | 8.08 | 3.08 | 5.59 | 5.59 | 15.05 | 6.70 | 0.9676 | 1.33 | 11.34 | 1,271,604.00 | 36.00 | 7.08 | 45.93 | 11.18 | 81.45 | 82.50 | 37.21 | 9.96 | 4.16 | 20.89 | 0.5422 | -- | 32.30 | 9.19 | 642.45 | -- | 34.71 | -- |
Data as of Jul 11 2025. Currency figures normalised to Formycon AG's reporting currency: Euro EUR
9.65%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Active Ownership Corp SARLas of 31 Dec 2023 | 1.07m | 6.08% |
| Norges Bank Investment Managementas of 31 Dec 2024 | 160.11k | 0.91% |
| Plutos Verm�gensverwaltung AGas of 31 Mar 2024 | 100.00k | 0.57% |
| ACATIS Investment Kapitalverwaltungsgesellschaft mbHas of 30 Apr 2025 | 80.00k | 0.45% |
| Lupus alpha Asset Management AGas of 30 Jun 2024 | 61.00k | 0.35% |
| Paladin Asset Management Investmentaktiengesellschaft TGVas of 30 Jun 2024 | 60.00k | 0.34% |
| BlackRock Asset Management Deutschland AGas of 04 Jul 2025 | 48.16k | 0.27% |
| MPPM Manfred Piontke Portfolio Management e.K.as of 30 Sep 2024 | 44.00k | 0.25% |
| Amundi Asset Management SASU (Investment Management)as of 02 Jul 2025 | 40.77k | 0.23% |
| Cr�dit Mutuel Asset Management SAas of 29 Dec 2023 | 36.48k | 0.21% |
More ▼
Data from 30 Jun 2024 - 09 Jul 2025Source: FactSet Research Systems Inc.
